Company Directory > CRO > PBS Regulatory Consulting

PBS Regulatory Consulting

Bridgewater, New Jersey, USA
VISIT WEBSITE
PBS Regulatory Consulting is a boutique professional services firm specializing in global regulatory affairs, quality assurance, and clinical compliance for the life sciences industry. The firm provides end-to-end support for drug development, from early-stage discovery through post-marketing surveillance. The company is known for its expertise in navigating complex regulatory pathways, including expedited programs like Breakthrough Therapy, Fast Track, and Priority Review. They serve a diverse clientele ranging from virtual startups to mid-sized biotechnology firms, helping them interface with health authorities such as the FDA, EMA, and Health Canada.
CLASSIFICATION
Company Type:CRO
Industry:Pharmaceuticals
Sub-Industry:Regulatory Consulting & CRO Services
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2007
Ownership:private
Status:operating
FUNDING
Stage:Bootstrapped/Self-funded
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A - Service Provider
Modalities:Small molecule, Biologics, Cell & Gene Therapy, Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Collaborations with various clinical research organizations (CROs), Partnerships with specialized CMC manufacturing consultants
COMPETITION
Position:Niche Player
Competitors:Halloran Consulting Group, Cardinal Health Regulatory Sciences, Lachman Consultant Services, ProPharma Group, Parexel Consulting
LEADERSHIP
Key Executives:
Priya Jambhekar - President & CEO
Scientific Founders:Priya Jambhekar
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PBS Regulatory Consulting. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.